Join
Live feed
·
PRReleasevia Quantisnow
Oruka Therapeutics Inc. logo

Oruka Therapeutics Announces Positive Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Phase 2a Trial in Moderate-to-Severe Plaque Psoriasis

ByQuantisnow·Wall Street's wire, on your screen.
ORKA· Oruka Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ORKA (Oruka Therapeutics Inc.) and more on Quantisnow.